Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Broadwood Capital Inc | 49.56M | $64.0M | 19.60% | -- | 2026-06-30 |
| BlackRock, Inc. | 13.19M | $17.0M | 5.21% | +9.32M | 2026-06-30 |
| Vanguard Capital Management LLC | 9.05M | $11.0M | 3.58% | +736.2K | 2026-06-30 |
| Defender Capital, LLC. | 6.60M | $8.0M | 2.61% | -130.7K | 2026-06-30 |
| Geode Capital Management, LLC | 5.30M | $6.0M | 2.10% | +2.78M | 2026-06-30 |
| Fifth Third Bancorp | 4.60M | $6.0M | 1.82% | -- | 2026-06-30 |
| Millennium Management LLC | 3.02M | $3.0M | 1.19% | -2.54M | 2026-06-30 |
| State Street Corp | 2.31M | $3.0M | 0.92% | +1.22M | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 1.67M | $2.0M | 0.66% | +344.5K | 2026-06-30 |
| Northern Trust Corp | 1.66M | $2.0M | 0.66% | +1.16M | 2026-06-30 |
